TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: perceived pain during arterial puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative take-home baby rate
Endpoint domain: Mortality/survival
Primary endpoint: ongoing implantation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: major congenital anomalies incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in blood markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Resolution of inflammatory and immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: %BV/TV (Bone Volume/Total Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %BIC (Bone-Implant Contact)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in sedentary behavior (SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of riamilovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of riamilovir
Endpoint domain: Adverse events/effects
Primary endpoint: Vascular access failure
Endpoint domain: Adverse events/effects
Primary endpoint: Chair rise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Leg extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Posterior displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inferior displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drain displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV shedding prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Viral load ≥5 log‐copies CMV/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: KDQOL‐36 Mental Component Summary (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decisional conflict (DCS total score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in problem severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Global Longitudinal Strain (LV GLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Additional QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disaster response preparedness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient evacuation preparedness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication ratings with charge nurse and family
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Detection of COVID-19 up to 2 days prior to symptom onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on questionnaire measures of ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on executive function measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects (headaches)
Endpoint domain: Adverse events/effects
Primary endpoint: percentage score of satisfaction on the endoscopic procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: social health improvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Clinical and dermoscopic clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAPS-5 change from baseline at week 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of COVID-19 infection
Endpoint domain: Mortality/survival
Primary endpoint: TBUT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Schirmer I test value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Establishment of a compromised microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to first clinically meaningful worsening for physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median time to first clinically meaningful worsening for role functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Median time to first clinically meaningful worsening for fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Median time to first clinically meaningful worsening for pain
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: cumulative incidences of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of reseating of the LMA mask
Endpoint domain: Adverse events/effects
Primary endpoint: Mean peripheral oxygen saturation (Spo2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: risk for ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk for bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: MCCB total score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Current alcohol use during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency through 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of major adverse event (MAE) through 48 months
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality rate through 48 months
Endpoint domain: Mortality/survival
Primary endpoint: Time to full feeding (TFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection rate of high-risk FDLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First puff liking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seroconversion rate of SARS-CoV-2 neutralising antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean concentration (GMC) of Streptococcus pneumoniae IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BMD evaluation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OPT initiation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression toward respiratory insufficiency or neurological complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: social issues
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of days alive and out of hospital at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: SBM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: GSRS-constipation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Undesired Medication Events (UMD)
Endpoint domain: Adverse events/effects
Primary endpoint: hair density and thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with pain controlled (VAS<6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamometry results in both hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate skin-prick test wheal or flare size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Compatible Crossmatches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate CCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target serum PTH level maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum Klotho level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glomerular filtration rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnosis of PNES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of COVID-19 events
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of ILI events
Endpoint domain: Mortality/survival
Primary endpoint: Health change (SF-36 questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum vancomycin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Job satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived chronic stress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NfL (Neurofilament light chain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: YKL-40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reversal of white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of COVID-19 cases
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine efficacy against severe disease
Endpoint domain: Mortality/survival
Primary endpoint: Renal oxygenation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: increase in root canal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: facial affect recognition skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in indentation index of periorbital wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to relapse of periorbital wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: menopause-specific beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse effects (shoulder pain)
Endpoint domain: Adverse events/effects
Primary endpoint: composite responder rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kt/V (dialysis adequacy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urea reduction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the receiver operating characteristic curve (AUC) for diagnosing hepatic steatosis (HS) ≥ S1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Time to deterioration (TtD)
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Lower limbs muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinically significant anxiety reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived exertion at the end of resistance exercise session
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Endothelial progenitor cells (EPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: p16INK4a mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: average postoperative day 1 pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude toward disabled persons
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Alexithymia score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: live birth rate (LBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: spontaneous miscarriage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: QTcI (corrected QT interval)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to complete scenarios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of scenario completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drug-related minor side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change in glycated hemoglobin (HgbA1c) percentages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in high-density lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median total score on the EVAN-LR questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NRT consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate of African Americans
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weight increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of metabolic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oedema measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SmO2 resaturation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of substandard medicines
Endpoint domain: Adverse events/effects
Primary endpoint: anxious symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in hypoglycemic state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Residual neuromuscular block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Pain-related disability (RMDQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Increased risk of RA per SD increment in genetically predicted BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OA Necessity beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concern beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unplanned ICU admission rate
Endpoint domain: Mortality/survival
Primary endpoint: Bayley‐III cognitive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged Overall Survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Improved PSA Response Rate (PSA-RR)
Endpoint domain: Physiological/clinical
Primary endpoint: OSATS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of propofol MCT/LCT preparations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative failure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of severe mental distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to influenza symptom resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of influenza-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time to intervention for CNS disease
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Parental satisfaction with child's dental health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postprandial TG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient access
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Value for money
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reductions in grief symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grief-related impairment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completion of primary school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Transition to secondary school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: School enrollment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: incidence of serious irAEs
Endpoint domain: Adverse events/effects
Primary endpoint: quality of life (QOL) level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time implementing follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean time to electrographic seizure termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to clinical seizure termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial oxygen saturation values (SaO2) 24 h after surfactant administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum γ-hydroxybutyrate plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GHB plasma concentrations 8 hours post dose (C8h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State‐Trait Anxiety Inventory‐Global scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hamilton Depression Rating Scale, 21‐item version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Major/CRNM bleeding event rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Occurrence of myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: alanine aminotransferase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: NAFLD activity score (NAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: liver fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: NLN core competency skill acquisition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood βHB concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: redislocations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return to previous top level of competitive sports
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Iron deficiency (ID) and iron deficiency anemia (IDA) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posttraumatic irritability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influence on clinical decision-making processes
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: maximum antimicrobial efficacy against E. faecalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Surgical Site Infections (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: YGTSS-TTS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PCI related severe myocardial injury or myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of TEA treatment on knee osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety of TEA treatment on knee osteoarthritis
Endpoint domain: Adverse events/effects
Primary endpoint: Uterine aspiration pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of secondary adhesive capsulitis
Endpoint domain: Adverse events/effects
Primary endpoint: mean amblyopic-eye VA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Pain-Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Oswestry Disability Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear-Avoidance Beliefs Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes